Mylan

NASDAQ

MYL

Stock

Yield per half year: 0%
Dividend yield: 0%
Sector: Healthcare

Compare companies

Download the report:

Excel

Word

PDF

	Mylan	Gilead Sciences	Amgen
Capitalization
Price	0.079	105.93	280.35
Price priv.
Number of shares, million		1255	541
Capitalization, billion	8.19	94.55	140.05
EBITDA, billion	2.72	4.43	13.36
EV, billion	16.63	132.64	189.13
Profit and loss report
Net profit, billion	0.2664	0.48	4.09
Revenue, billion	11.51	28.75	33.42
EPS	-2.32	0.3825	7.56
Balance
Assets, billion	31.24	59	91.84
Debt, billion	9.23	26.71	60.1
Balance cost, billion	-8.24	19.33	5.88
Cash, billion	0.7956	9.99	11.97
Coefficients
Dividend yield, %	0	3.17	2.94
Dividend	0	3.12	9.26
Dividend yield priv., %	0	0	0
Dividend priv.	0	0	0
Dividends/profit, %	0	816.25	118.14
P/S	0.71	4.03	4.22
P/BV	0.73	6.02	23.99
P/E	133.29	241.51	34.48
Ev/Ebitda	7.46	29.92	14.16
Debt/Ebitda	3.4	6.02	4.5
Efficiency
ROE	-12.42	2.28	67.55
ROA	-4.64	0.7926	4.33
ROIC	-4.82	11.06	17
Ebitda margin	23.61	15.42	39.96
Net margin	-4.5	1.67	12.24
Momentum
1 week, price changes	0 %	-2.37 %	-3.1 %
1 month, price changes	0 %	-2.83 %	-2.32 %
3 months, price changes	0 %	+0.3981 %	+0.7004 %
6 months, price changes	0 %	+1.78 %	-3.71 %
1 year, price changes	0 %	+27.92 %	-15.67 %
3 years, price changes		+66.11 %	+24.04 %
5 years, price changes		+63.9 %	+12.95 %
10 years, price changes	-99.8 %	+47.93 %	+86.42 %

More data >>

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe